Cristina Martinez-Molina

6PUBLICATIONS
13CO-AUTHORS
Rheumatology and arthritisClinical pharmacology and therapeuticsCancer therapy (excl. chemotherapy and radiation therapy)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 31, 2026
Factors associated with the effectiveness and safety of Janus kinase inhibitors in rheumatoid arthritis: an 8-year observational study from the JAGUAR Registry.

|Jun 13, 2025
Etrasimod: Modulating Sphingosine-1-Phosphate Receptors to Treat Ulcerative Colitis.

Cristina Martinez-Molina, Begoña González-Suárez

|Apr 27, 2024
Are There Sex-Related Differences in the Effectiveness of Janus Kinase Inhibitors in Rheumatoid Arthritis Patients?

Cristina Martinez-Molina, Anna Feliu, Hye S Park

|Mar 28, 2024
Tofacitinib and Baricitinib in Type 2 Diabetic Patients with Rheumatoid Arthritis.

Cristina Martinez-Molina, Cesar Diaz-Torne, Hye S Park

|Jan 03, 2024
Patient-related factors influencing the effectiveness and safety of Janus Kinase inhibitors in rheumatoid arthritis: a real-world study.

Cristina Martinez-Molina, Ignasi Gich, Cesar Diaz-Torné

|Oct 13, 2023
Are all JAK inhibitors for the treatment of rheumatoid arthritis equivalent? An adjusted indirect comparison of the efficacy of tofacitinib, baricitinib, upadacitinib, and filgotinib.

Lucía Vallez-Valero, Ingrid Gasó-Gago, Ángel Marcos-Fendian

Pageof 1

Frequent Collaborators

5 joint publications

Hèctor Corominas

3 joint publications

Cesar Diaz-Torné

3 joint publications

Hye S Park

3 joint publications

Anna Feliu